Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aarey Drugs & Pharmaceuticals is an India-based publicly listed manufacturer of active pharmaceutical ingredients, intermediates, and specialty chemicals. The company also trades industrial solvents and chemicals, serving pharmaceutical formulation manufacturers as well as merchant export markets. Its disclosed product portfolio includes APIs such as metformin hydrochloride, mefenamic acid, doxofylline, lumefantrine, nimesulide, albendazole, carbamazepine, and oxcarbazepine, alongside chemical intermediates such as mono methyl urea and dimethyl urea. Operations appear centered on manufacturing at Tarapur/Boisar in Maharashtra with head office functions in Mumbai. The business is best characterized as a commercial-stage small-molecule API and chemicals manufacturer rather than a novel-drug biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aarey Drugs & Pharmaceuticals.